Source-grounded facts extracted from Hinge Health, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Hinge Health, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.
“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm. Votes For Votes Against Abstentions 305,789,374 121,058 69,093”
Hinge Health, Inc. shareholders approved Election of Class I Directors: Teddie Wardi and Tyler Sloat at the 2026-06-03 meeting.
“Proposal 1: Election of Class I Director Nominees . Nominees Votes For Votes Withheld Broker Non-Votes Teddie Wardi 276,921,911 14,888,631 14,168,983 Tyler Sloat 291,330,022 480,520 14,168,983”
Hinge Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $182.3 million, EPS $0.41. Guidance raised.
“results San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes”
Hinge Health, Inc.: Amended and restated bylaws became effective upon closing of IPO (effective 2025-05-23).
“and its amended and restated bylaws (the “Bylaws”) became effective, in connection with the closing of the initial public offering”
Hinge Health, Inc.: Filed amended and restated certificate of incorporation upon closing of IPO (effective 2025-05-23).
“On May 23, 2025, Hinge Health, Inc. (the “Company”) filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.